Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
AOB8067
CAS: 693241-54-2
Chemical Name: 2-[[4-[(2-Methoxybenzoyl)amino]benzoyl]amino]-benzoic acid
Warning: Last items in stock!
Availability date:
Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
---|---|---|---|
1 | 100 | $16.65 | Total: $1,665.00 |
1 | 50 | $19.24 | Total: $962.00 |
1 | 25 | $22.57 | Total: $564.25 |
1 | 10 | $26.64 | Total: $266.40 |
1 | 5 | $31.45 | Total: $157.25 |
Molecular Formula | C22H18N2O5 |
Molecular Weight | 390.40 |
CAS Numbers | 693241-54-2 |
Storage Condition | 0°C (short term), -20°C (long term), desiccated |
Solubility | DMSO |
Purity | 98% by HPLC |
Synonym | EG-1; EG 1 |
IUPAC/Chemical Name | 2-[[4-[(2-Methoxybenzoyl)amino]benzoyl]amino]-benzoic acid |
InChl Key | GYZZRJRJYVMXNS-UHFFFAOYSA-N |
InChl Code | InChI=1S/C22H18N2O5/c1-29-19-9-5-3-7-17(19)21(26)23-15-12-10-14(11-13-15)20(25)24-18-8-4-2-6-16(18)22(27)28/h2-13H,1H3,(H,23,26)(H,24,25)(H,27,28) |
SMILES Code | O=C(O)C1=CC=CC=C1NC(C2=CC=C(NC(C3=CC=CC=C3OC)=O)C=C2)=O |
References | 1) Smith CB, et al., Using the New ASCO Clinical Practice Guideline for Palliative Care Concurrent With Oncology Care Using the TEAM Approach. Am Soc Clin Oncol Educ Book. 2017;37:714-723. doi: 10.14694/EDBK_175474. PubMed PMID: 28561696. 2) Masuda K, et al.' Erratum to: Serum HMGB1 concentrations at 4 weeks is a useful predictor of extreme poor prognosis for advanced hepatocellular carcinoma treated with sorafenib and hepatic arterial infusion chemotherapy. J Gastroenterol. 2017 May 29. doi: 10.1007/s00535-017-1352-z. [Epub ahead of print] PubMed PMID: 28555325. |
Novel specific inhibitor of Pax2 transcription activation, targeting the DNA binding domain and inhibiting embryonic kidney development